Top Page
Integrated Research Limited
(OTC:IRI)
Integrated Research Limited (IRI) vs. iShares MSCI Australia ETF (EWA)
Integrated Research Limited Business Overview & Revenue Model
Integrated Research Limited Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 68.26M | 68.26M | 83.29M | 69.83M | 62.87M | 78.49M |
| Gross Profit | 50.68M | 68.26M | 83.29M | 28.94M | 62.87M | 78.49M |
| EBITDA | 13.45M | 13.45M | 25.34M | -1.07M | 10.40M | 23.34M |
| Net Income | 13.36M | 13.36M | 27.13M | -29.23M | 1.54M | 7.93M |
Balance Sheet | ||||||
| Total Assets | 122.97M | 122.97M | 114.19M | 90.84M | 132.20M | 136.63M |
| Cash, Cash Equivalents and Short-Term Investments | 40.59M | 40.59M | 31.89M | 18.55M | 12.33M | 12.15M |
| Total Debt | 1.85M | 1.85M | 1.72M | 3.05M | 4.87M | 13.08M |
| Total Liabilities | 22.36M | 22.36M | 25.82M | 30.97M | 45.08M | 53.29M |
| Stockholders Equity | 100.62M | 100.62M | 88.36M | 59.87M | 87.11M | 83.34M |
Cash Flow | ||||||
| Free Cash Flow | 8.18M | 8.18M | 15.22M | 8.20M | 6.97M | 9.67M |
| Operating Cash Flow | 8.68M | 8.68M | 13.04M | 15.99M | 18.76M | 21.91M |
| Investing Cash Flow | 1.17M | 4.12M | 2.27M | -8.90M | -11.80M | -12.24M |
| Financing Cash Flow | -4.90M | -5.00M | -1.69M | -1.63M | -6.96M | -6.44M |
Integrated Research Limited Technical Analysis
Integrated Research Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | AU$56.89M | 4.17 | 13.76% | 6.56% | -18.05% | -51.45% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
48 Neutral | AU$26.60M | -4.05 | -31.01% | ― | -3.43% | -40.65% | |
41 Neutral | AU$13.64M | ― | -133.07% | ― | -4.90% | -52.78% | |
41 Neutral | AU$56.72M | -7.97 | ― | ― | 21.82% | 6.83% | |
35 Underperform | AU$82.41M | -14.74 | ― | ― | ― | ― |
Integrated Research Limited Corporate Events
Integrated Research Limited has announced a trading update for the half-year ending December 2025, highlighting the momentum of its product-led growth strategy with increased investments and new product launches. Despite these efforts, the company anticipates softer revenue compared to the previous year due to weaker renewals and increased allowances for expected credit losses, leading to an expected EBITDA loss ranging from $3 million to $8 million.
The most recent analyst rating on (AU:IRI) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.
Integrated Research Limited has released its 2025 Annual Report, highlighting its continued focus on optimizing operations of mission-critical systems and enhancing user experience. The report underscores the company’s strategic positioning in the global market for performance management solutions, emphasizing its role in enabling seamless transactions and collaborations for major organizations worldwide.
The most recent analyst rating on (AU:IRI) stock is a Hold with a A$0.50 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.
Integrated Research Limited has announced that its 2025 Annual General Meeting will be held on November 24, 2025. The company also stated that nominations for director positions must be submitted by September 26, 2025. This meeting is significant for stakeholders as it provides an opportunity to influence the company’s governance and strategic direction.
The most recent analyst rating on (AU:IRI) stock is a Buy with a A$0.55 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.
Integrated Research Limited has announced the quotation of 3,239,095 fully paid ordinary securities on the Australian Securities Exchange (ASX) as of September 15, 2025. This move is part of the company’s strategy to enhance its market presence and provide liquidity to its stakeholders, potentially impacting its operational capabilities and industry positioning positively.
The most recent analyst rating on (AU:IRI) stock is a Buy with a A$0.55 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.
Integrated Research Limited (IR) is a company specializing in the design, development, and sale of software for real-time monitoring of business-critical computing environments, particularly in Unified Communication and Payment networks. Operating globally, IR serves major organizations across various sectors, including banking and telecommunications.
Integrated Research Limited has released its Appendix 4G and Corporate Governance Statement, authorized by the Board. This announcement highlights the company’s adherence to the ASX Corporate Governance Council’s principles and recommendations, ensuring transparency and compliance. The governance statement, available on the company’s website, is up-to-date as of August 26, 2025, and reflects the company’s commitment to maintaining high governance standards, which is crucial for stakeholders and market positioning.
The most recent analyst rating on (AU:IRI) stock is a Buy with a A$0.70 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.
Integrated Research Limited announced its full-year financial results for the year ending June 30, 2025. The company continues to focus on enhancing its market positioning by delivering innovative solutions that simplify complex systems and improve user experiences. This announcement underscores IR’s commitment to leveraging its technology and expertise to support the operational needs of large organizations, potentially impacting stakeholders by reinforcing its role as a critical player in the industry.
The most recent analyst rating on (AU:IRI) stock is a Buy with a A$0.70 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.
Integrated Research Limited reported its FY25 financial results, highlighting a strategic pivot towards product-led growth with a focus on new product development and commercialization. Despite a challenging year with a decrease in statutory revenue and net profit, the company saw a 31% increase in revenue from new clients and a 77% rise in consumption-based revenue. The launch of new products and a significant contract renewal with JP Morgan Chase are expected to bolster future growth, although market uncertainties in the Americas have posed challenges.
The most recent analyst rating on (AU:IRI) stock is a Buy with a A$0.70 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.
Integrated Research Limited has announced a dividend distribution of AUD 0.020 per share for the period ending June 30, 2025. The ex-dividend date is set for September 3, 2025, with the record date on September 4, 2025, and payment scheduled for October 21, 2025. This announcement reflects the company’s ongoing commitment to returning value to its shareholders and may impact its market positioning by attracting investor interest.
The most recent analyst rating on (AU:IRI) stock is a Buy with a A$0.70 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.
Integrated Research Limited has reported a significant decline in its financial performance for the year ending June 30, 2025, with revenues dropping by 18% to A$68,256,000 and net profit falling by 51% to A$13,358,000. Despite these challenges, the company declared a fully franked final dividend of 2.0 cents per share, maintaining the same dividend as the previous year, which reflects the company’s commitment to returning value to shareholders amidst a challenging market environment.
The most recent analyst rating on (AU:IRI) stock is a Buy with a A$0.70 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.
Integrated Research Limited announced it will release its full-year earnings for the period ending June 30, 2025, on August 26, 2025. A conference call will be held on the same day, hosted by CEO Ian Lowe and CFO Christian Shaw, to discuss the earnings. This announcement signifies the company’s ongoing commitment to transparency and stakeholder engagement, potentially impacting its market positioning and investor relations.
The most recent analyst rating on (AU:IRI) stock is a Buy with a A$0.70 price target. To see the full list of analyst forecasts on Integrated Research Limited stock, see the AU:IRI Stock Forecast page.